In addition, researchers have developed a multifunctional biomimetic nanoplatform (referred to as HM-BPT), which utilizes pH-sensitive tumor-targeting hybrid membrane-coated manganese oxide nanoparticles for the delivery of the glutaminase inhibitor BPTES. This evidence concerns the gene GLS and neoplasm.